Overview

Bioequivalence of Ketoprofen Oral Gel vs Ketoprofen Lysine Salt as Granules for Oral Solution

Status:
Completed
Trial end date:
2018-08-05
Target enrollment:
Participant gender:
Summary
This is a single dose, open-label, randomised, two period, two-way cross-over, two stage bioequivalenve study with the aim to investigate the bioequivalence between a new formulation of ketoprofen 25 mg versus OKI 80 mg granules for oral solution (half sachet), after single dose administration in two consecutive periods to healthy voluteers under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborator:
Cross Research S.A.
Treatments:
Ketoprofen
Ketoprofen lysine